Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
| + | *[[Media:2019_04-09_QIBA_SPECT_TC99M_Call Summary-FINAL.post-Moz.pdf | April 9, 2019]] | ||
*[[Media:2019_03-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | March 12, 2019]] | *[[Media:2019_03-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | March 12, 2019]] | ||
*[[Media:2019_02-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | February 12, 2019]] | *[[Media:2019_02-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | February 12, 2019]] | ||
Revision as of 21:58, 11 April 2019
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- Secretary: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology
Recent Meetings/Call Summaries
- April 9, 2019
- March 12, 2019
- February 12, 2019
- January 15, 2019
- November 13, 2018
- October 9, 2018
- September 11, 2018
- August 14, 2018
- July 10, 2018